News & Articles

Improve reproducibility of in vivo studies using mouse models

MRD testing without personalization and clinical utility of liquid biopsy platform demonstrated in multiple indications

The new platform has been designed to enable faster analysis of PhenoCycler-Fusion data

The new kit is designed to allow researchers to easily and consistently generate muscle from human pluripotent stem cells

Meet the 3D cell culture technology that is breaking boundaries in cancer research, drug discovery, and beyond

Thermo Fisher Scientific, Sony Biotechnology, and Logos Biosystems among those recognized

Chemically defined media optimized for growth and productivity of CHO cells in perfusion and batch and fed-batch bioprocesses

Discover the latest products that have earned Seal of Quality awards, including a never-before-seen triple platinum announcement

Competition for NGS scientists to win a MagicPrep NGS system

Advanced library amplification to reduce GC-bias and push the limits of NGS data

CrestOptics lauches CICERO: The cost effective solution for widefield and confocal imaging

Fujirebio adds another two markers to its fully automated blood-based biomarker portfolio

Enhanced usability to support PCR applications in basic and translational research, process development, and quality control

Learn more about biophysical characterization technology and how it can help to advance your drug discovery and biotherapeutic workflows

The new biomarker tests will allow further study of the clinical utility of NfL in diverse disease conditions

A new high-quality, cleverly designed liquid handling device can help combat common challenges and accelerate scientific development

Explore the importance of stabilizing temperature in microplate reading technology to achieve robust and reproducible data in your drug discovery workflows

Join industry leaders across Europe in therapeutic drug development to share insights, drive investment, and build new partnerships

Discover how the Seward Stomacher lab blender is designed to reduce cross-contamination and provide compliant, viable test results

Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders